News tagged with erlotinib

Related topics:

Assessing positive outcomes of phase III trials

Randomized phase III studies should be designed to find out whether a new drug or treatment makes a meaningful difference in patients' survival or quality of life, according to a commentary published online December 3rd in ...

Dec 03, 2010
not rated yet 0

Economic analysis: Erlotinib marginally cost-effective

Weighing both magnitude of survival benefit and expense, researchers found that the drug erlotinib, which was found to improve overall survival by 2 months in patients with advanced non-small cell lung cancer, is marginally ...

Feb 16, 2010
not rated yet 0